1,520
Views
0
CrossRef citations to date
0
Altmetric
Anesthesiology

A brief review of complex regional pain syndrome and current management

, , , , , , , , & show all
Article: 2334398 | Received 31 Oct 2023, Accepted 28 Feb 2024, Published online: 03 Apr 2024

References

  • Goh EL, Chidambaram S, Ma D. Complex regional pain syndrome: a recent update. Burns Trauma. 2017;5(1):1. doi: 10.1186/S41038-016-0066-4.
  • Ott S, Maihöfner C. Signs and symptoms in 1,043 patients with complex regional pain syndrome. J Pain. 2018;19(6):599–17. doi: 10.1016/J.JPAIN.2018.01.004.
  • Moretti A, Palomba A, Paoletta M, et al. Complex regional pain syndrome in athletes: scoping review. Medicina. 2021;57(11):1262. doi: 10.3390/medicina57111262.
  • Shim H, Rose J, Halle S, et al. Complex regional pain syndrome: a narrative review for the practising clinician. Br J Anaesth. 2019;123(2):e424–e433. doi: 10.1016/J.BJA.2019.03.03.0
  • Urits I, Shen AH, Jones MR, et al. Complex regional pain syndrome, current concepts and treatment options. Curr Pain Headache Rep. 2018;22(2):10. doi: 10.1007/S11916-018-0667-7/TABLES/2.
  • Nazir SST, Ivan N, Antonella U, et al. Complex regional pain syndrome: a comprehensive review. Pain Ther. 2021;10(2):875–892. doi: 10.1007/S40122-021-00279-4.
  • Stanton-Hicks M, Jänig W, Hassenbusch S, et al. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain. 1995;63(1):127–133. doi: 10.1016/0304-3959(95)00110-E.
  • Harden RN, Bruehl S, Stanton-Hicks M, et al. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007;8(4):326–331. doi: 10.1111/j.1526-4637.2006.00169.x.
  • Knudsen LF, Terkelsen AJ, Drummond PD, et al. Complex regional pain syndrome: a focus on the autonomic nervous system. Clin Auton Res. 2019;29(4):457–467. doi: 10.1007/S10286-019-00612-0.
  • David Clark J, Tawfik VL, Tajerian M, et al. Autoinflammatory and autoimmune contributions to complex regional pain syndrome. Mol Pain. 2018;14:1744806918799127. doi: 10.1177/1744806918799127.
  • Bruehl S, Maihöfner C, Stanton-Hicks M, et al. Complex regional pain syndrome: evidence for warm and cold subtypes in a large prospective clinical sample. Pain. 2016;157(8):1674–1681. doi: 10.1097/J.PAIN.0000000000000569.
  • Ryskalin L, Ghelarducci G, Marinelli C, et al. Effectiveness of decision support to treat complex regional pain syndrome. Appl Sci. 2022;12(18):8979. doi: 10.3390/app12188979.
  • Misidou C, Charalampos P, Mediterr J. Complex regional pain syndrome: an update. Mediterr J Rheumatol. 2019;30(1):16–25. doi: 10.31138/mjr.30.1.16.
  • Baronio M, Sadia H, Paolacci S, et al. Molecular aspects of regional pain syndrome. Pain Res Manag. 2020;2020:7697214. doi: 10.1155/2020/7697214.
  • Dirckx M, Stronks DL, Van Bodegraven-Hof EAM, et al. Inflammation in cold complex regional pain syndrome. Acta Anaesthesiol Scand. 2015;59(6):733–739. doi: 10.1111/AAS.12465.
  • Sommer C, Leinders M, Üçeyler N. Inflammation in the pathophysiology of neuropathic pain. Pain. 2018;159(3):595–602. doi: 10.1097/J.PAIN.0000000000001122.
  • Bickel M. The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol. 1993;64(5 Suppl):456–460.
  • Bernhard S, Hug S, Stratmann AEP, et al. Interleukin 8 elicits rapid physiological changes in neutrophils that are altered by inflammatory conditions. J Innate Immun. 2021;13(4):225–241. doi: 10.1159/000514885.
  • Bharwani KD, Dik WA, Dirckx M, et al. Highlighting the role of biomarkers of inflammation in the diagnosis and management of complex regional pain syndrome. Mol Diagn Ther. 2019;23(5):615–626. doi: 10.1007/S40291-019-00417-X/TABLES/4.
  • Russo MA, Georgius P, Pires AS, et al. Novel immune biomarkers in complex regional pain syndrome. J Neuroimmunol. 2020;347:577330. doi: 10.1016/j.jneuroim.2020.
  • Alexander GM, Perreault MJ, Reichenberger ER, et al. Changes in immune and glial markers in the CSF of patients with complex regional pain syndrome. Brain Behav Immun. 2007;21(5):668–676. doi: 10.1016/J.BBI.2006.10.009.
  • Alexander GM, Van Rijn MA, Van Hilten JJ, et al. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain. 2005;116(3):213–219. doi: 10.1016/J.PAIN.2005.04.013.
  • Munts AG, Zijlstra FJ, Nibbering PH, et al. Analysis of cerebrospinal fluid inflammatory mediators in chronic complex regional pain syndrome related dystonia. Clin J Pain. 2008;24(1):30–34. doi: 10.1097/AJP.0B013E318156D961.
  • Veldman PH, Reynen HM, Arntz IE, et al. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 1993;342(8878):1012–1016. doi: 10.1016/0140-6736(93)92877-v.
  • Schinkel C, Gaertner A, Zaspel J, et al. Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. Clin J Pain. 2006;22(3):235–239. doi: 10.1097/01.AJP.0000169669.70523.F0.
  • Ribbers GM, Oosterhuis WP, Van Limbeek J, et al. Reflex sympathetic dystrophy: is the immune system involved? Arch Phys Med Rehabil. 1998;79(12):1549–1552. doi: 10.1016/S0003-9993(98)90418-X.
  • Parkitny L, McAuley JH, Di Pietro F, et al. Inflammation in complex regional pain syndrome. Neurology. 2013;80(1):106–117 doi: 10.1212/WNL.0B013E31827B1AA1.
  • Wehmeyer C, Pap T, Buckley CD, et al. The role of stromal cells in inflammatory bone loss. Clin Exp Immunol. 2017;189(1):1–11. doi: 10.1111/CEI.12979.
  • Bertolini DR, Nedwin GE, Bringman TS, et al. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature. 1986;319(6053):516–518. doi: 10.1038/319516a0.
  • Hashizume M, Hayakawa N, Mihara M. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-α and IL-17. Rheumatology. 2008;47(11):1635–1640. doi: 10.1093/RHEUMATOLOGY/KEN363.
  • Littlejohn G. Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome. Nat Rev Rheumatol. 2015;11(11):639–648. doi: 10.1038/nrrheum.2015.100.
  • Birklein F, Drummond PD, Li W, et al. Activation of cutaneous immune responses in complex regional pain syndrome. J Pain. 2014;15(5):485–495. doi: 10.1016/j.jpain.2014.01.490.
  • Li WW, Guo TZ, Shi X, et al. Neuropeptide regulation of adaptive immunity in the tibia fracture model of complex regional pain syndrome. J Neuroinflammation. 2018;15(1):105. doi: 10.1186/S12974-018-1145-1/FIGURES/11.
  • Marinus J, Moseley GL, Birklein F, et al. Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol. 2011;10(7):637–648. doi: 10.1016/S1474-4422(11)70106-5.
  • Kohr D, Tschernatsch M, Schmitz K, et al. Autoantibodies in complex regional pain syndrome bind to a differentiation-dependent neuronal surface autoantigen. Pain. 2009;143(3):246–251. doi: 10.1016/J.PAIN.2009.03.009.
  • Tajerian M, Clark JD. New concepts in complex regional pain syndrome. Hand Clin. 2016;32(1):41–49. doi: 10.1016/J.HCL.2015.08.003.
  • Cuhadar U, Gentry C, Vastani N, et al. Autoantibodies produce pain in complex regional pain syndrome by sensitizing nociceptors. Pain. 2019;160(12):2855–2865. doi: 10.1097/J.PAIN.0000000000001662.
  • Clatworthy MR, Aronin CEP, Mathews RJ, et al. Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes. Nat Med. 2014;20(12):1458–1463. doi: 10.1038/nm.3709.
  • Ratti C, Nordio A, Resmini G, et al. Post-traumatic complex regional pain syndrome: clinical features and epidemiology. Clin Cases Miner Bone Metab. 2015;12(Suppl 1):11–16. doi: 10.11138/CCMBM/2015.12.3S.011.
  • Osborne S, Farrell J, Dearman RJ, et al. Cutaneous immunopathology of long-standing complex regional pain syndrome. Eur J Pain. 2015;19(10):1516–1526. doi: 10.1002/EJP.685.
  • Russo M, Georgius P, Santarelli DM. A new hypothesis for the pathophysiology of complex regional pain syndrome. Med Hypotheses. 2018;119:41–53. doi: 10.1016/J.MEHY.2018.07.026.
  • Villablanca EJ, Mora JR. A two-step model for langerhans cell migration to skin-draining LN. Eur J Immunol. 2008;38(11):2975–2980. doi: 10.1002/EJI.200838919.
  • Pleger B, Tegenthoff M, Ragert P, et al. Sensorimotor retuning [corrected] in complex regional pain syndrome parallels pain reduction. Ann Neurol. 2005;57(3):425–429. doi: 10.1002/ANA.20394.
  • Sigtermans MJ, van Hilten JJ, Bauer MCR, et al. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain. 2009;145(3):304–311. doi: 10.1016/J.PAIN.2009.06.02.3
  • Bruehl S. An update on the pathophysiology of complex regional pain syndrome. Anesthesiology. 2010;113(3):713–725. doi: 10.1097/ALN.0B013E3181E3DB38.
  • Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett. 2004;361(1-3):184–187. doi: 10.1016/j.neulet.2003.12.007.
  • Lebel A, Becerra L, Wallin D, et al. fMRI reveals distinct CNS processing during symptomatic and recovered complex regional pain syndrome in children. Brain. 2008;131(Pt 7):1854–1879. doi: 10.1093/BRAIN/AWN123.
  • Davis KD, Kiss ZHT, Tasker RR, et al. Thalamic stimulation-evoked sensations in chronic pain patients and in nonpain (movement disorder) patients. J Neurophysiol. 1996;75(3):1026–1037. doi: 10.1152/JN.1996.75.3.1026.
  • Van Hilten JJ, Van de Beek WJT, Vein AA, et al. Clinical aspects of multifocal or generalized tonic dystonia in reflex sympathetic dystrophy. Neurology. 2001;56(12):1762–1765. doi: 10.1212/WNL.56.12.1762.
  • Le Bars D, Cadden SW. What is a wide-dynamic-range cell? The Senses: a Comprehensive Reference. 2008;5:331–338. doi: 10.1016/B978-012370880-9.00167-5.
  • Vera-Portocarrero LP, Zhang ET, Ossipov MH, et al. Descending facilitation from the rostral ventromedial medulla maintains nerve injury-induced central sensitization. Neuroscience. 2006;140(4):1311–1320. doi: 10.1016/J.NEUROSCIENCE.2006.03.016.
  • Harden RN, Rudin NJ, Bruehl S, et al. Increased systemic catecholamines in complex regional pain syndrome and relationship to psychological factors: a pilot study. Anesth Analg. 2004;99(5):1478–1485. doi: 10.1213/01.ANE.0000132549.25154.ED.
  • Bruehl S, Chung OY. Psychological and behavioral aspects of complex regional pain syndrome management. Clin J Pain. 2006;22(5):430–437. doi: 10.1097/01.AJP.0000194282.82002.79.
  • Reimer M, Rempe T, Diedrichs C, et al. Sensitization of the nociceptive system in complex regional pain syndrome. PLOS One. 2016;11(5):e0154553. doi: 10.1371/JOURNAL.PONE.0154553.
  • Drummond PD. Neuronal changes resulting in up-regulation of alpha-1 adrenoceptors after peripheral nerve injury. Neural Regen Res. 2014;9(14):1337–1340. doi: 10.4103/1673-5374.137583.
  • Johnson T. The collected works of ambroise paré. New York: Milford House; 1968.
  • Denmark A. An example of symptoms resembling tic douleureux, produced by a wound in the radial nerve. Med Chir Trans. 1813;4:48–52.
  • Mitchell SW, Morehouse GR, Keen WW. Gunshot wounds and other injuries of nerves. Clin Orthop Relat Res. 2007;458:35–39. doi: 10.1097/BLO.0b013e31803df02c.
  • Stanton-Hicks M. CRPS: what’s in a name? Taxonomy, epidemiology, neurologic, immune and autoimmune considerations. Reg Anesth Pain Med. 2019;44(3):376–387. doi: 10.1136/rapm-2018-100064.
  • Leriche R. De la causalgie envisagee comme une nervrite du sympathique et son traitement par la denuation et l’excision des plexus nerveux periarteriels. Presse Med. 1916;24:178–180.
  • Kessler A, Yoo M, Calisoff R, et al. Complex regional pain syndrome: an updated comprehensive review. NeuroRehabilitation. 2020;47(3):253–264. doi: 10.3233/NRE-208001.
  • Evans JA. Reflex sympathetic dystrophy. Surg Clin North Am. 1946;26:780–790.
  • Castillo-Guzmán S, Nava-Obregón TA, Palacios-Ríos D, et al. Complex regional pain syndrome (CRPS), a review. Medicina Universitaria. 2015;17(67):114–121. doi: 10.1016/j.rmu.2015.03.003.
  • Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the international association for the study of pain, subcommittee on taxonomy. Pain Suppl. 1986;3:S1–S226.
  • Williams K, Guarino A, Raja SN. Chapter 27 – Complex regional pain syndrome. In: Benzon HT, Raja SN, Liu SS, et al., eds. Essentials of pain medicine. 4th ed. Philadelphia: Elsevier; 2018:223.e2–232.e2. doi: 10.1016/B978-0-323-40196-8.00027-9.
  • Harden RN, Bruehl S, Perez RSGM, et al. Validation of proposed diagnostic criteria (the “budapest criteria”) for complex regional pain syndrome. Pain. 2010;150(2):268–274. doi: 10.1016/j.pain.2010.04.030.
  • Goebel A, Birklein F, Brunner F, et al. The Valencia consensus-based adaptation of the IASP complex regional pain syndrome diagnostic criteria. Pain. 2021;162(9):2346–2348. doi: 10.1097/j.pain.0000000000002245.
  • Mesaroli G, Hundert A, Birnie KA, et al. Screening and diagnostic tools for complex regional pain syndrome: a systematic review. Pain. 2021;162(5):1295–1304. doi: 10.1097/j.pain.0000000000002146.
  • Tahmoush AJ. Causalgia: redefinition as a clinical pain syndrome. Pain. 1981;10(2):187–197. doi: 10.1016/0304-3959(81)90194-9.
  • Sandroni P, Low PA, Ferrer T, et al. Complex regional pain syndrome I (CRPS I): prospective study and laboratory evaluation. Clin J Pain. 1998;14(4):282–289. doi: 10.1097/00002508-199812000-00003.
  • Thomson McBride AR, Barnett AJ, Livingstone JA, et al. Complex regional pain syndrome (type 1): a comparison of 2 diagnostic criteria methods. Clin J Pain. 2008;24(7):637–640. doi: 10.1097/AJP.0b013e31817591da.
  • Sumitani M, Shibata M, Sakaue G, et al. Development of comprehensive diagnostic criteria for complex regional pain syndrome in the Japanese population. Pain. 2010;150(2):243–249. doi: 10.1016/j.pain.2010.03.03.2
  • Dommerholt J. Complex regional pain syndrome—1: history, diagnostic criteria and etiology. J Bodyw Mov Ther. 2004;8(3):167–177. doi: 10.1016/S1360-8592(03)00100-1.
  • Goebel A, Barker C, Birklein F, et al. Standards for the diagnosis and management of complex regional pain syndrome: results of a European pain federation task force. Eur J Pain. 2019;23(4):641–651. doi: 10.1002/ejp.1362.
  • Shin SH, Kim SJ. Bone scintigraphy in patients with pain. Korean J Pain. 2017;30(3):165–175. doi: 10.3344/kjp.2017.30.3.165.
  • Ringer R, Wertli M, Bachmann LM, et al. Concordance of qualitative bone scintigraphy results with presence of clinical complex regional pain syndrome 1: meta‐analysis of test accuracy studies. Eur J Pain. 2012;16(10):1347–1356. doi: 10.1002/j.1532-2149.2012.00137.x.
  • Wertli MM, Brunner F, Steurer J, et al. Usefulness of bone scintigraphy for the diagnosis of complex regional pain syndrome 1: a systematic review and Bayesian meta-analysis. PLOS One. 2017;12(3):e0173688. doi: 10.1371/journal.pone.0173688.
  • Pérez-Concha T, Tijero B, Acera M, et al. Usefulness of thermography in the diagnosis and classification of complex regional pain syndrome. Neurología. 2020;38(5):342–349. doi: 10.1016/j.nrl.2020.10.011.
  • Lubkowska A, Pluta W. Infrared thermography as a Non-Invasive tool in musculoskeletal disease rehabilitation–The control variables in applicability–A systematic review. Appl Sci. 2022;12(9):4302. doi: 10.3390/app12094302.
  • Bruehl S, Harden RN, Galer BS, et al. Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome? Pain. 2002;95(1-2):119–124. doi: 10.1016/s0304-3959(01)00387-6.
  • Collins CK. Physical therapy management of complex regional pain syndrome I in a 14-year-old patient using strain counterstrain: a case report. J Man Manip Ther. 2007;15(1):25–41 doi: 10.1179/106698107791090150.
  • Menck JY, Requejo SM, Kulig K. Thoracic spine dysfunction in upper extremity complex regional pain syndrome type I. J Orthop Sports Phys Ther. 2000;30(7):401–409. doi: 10.2519/JOSPT.2000.30.7.401.
  • Cleland J, McRae M. Complex regional pain syndrome I: management through the use of vertebral and sympathetic trunk mobilization. J Man Manip Ther. 2002;10(4):188–199. doi: 10.1179/106698102790819067.
  • Gutiérrez-Espinoza H, Tabach-Apraiz A, Oyanadel-Maldonado M. Physical therapy in patients with complex regional pain syndrome type I after distal radius fracture: a case series. J Phys Ther Sci. 2019;31(4):403–407. doi: 10.1589/JPTS.31.40.3
  • Walston Z, Hernandez L, Yake D. Utilization of manual therapy to the lumbar spine in conjunction with traditional conservative care for individuals with bilateral lower extremity complex regional pain syndrome: A case series. Physiother Theory Pract. 2018;36(1):241–248. doi: 10.1080/09593985.2018.1482392.
  • Albazaz R, Wong YT, Homer-Vanniasinkam S. Complex regional pain syndrome: a review. Ann Vasc Surg. 2008;22(2):297–306. doi: 10.1016/J.AVSG.2007.10.006.
  • Fialka V, Korpan M, Saradeth T, et al. Autogenic training for reflex sympathetic dystrophy: a pilot study. Complement Ther Med. 1996;4(2):103–105. doi: 10.1016/S0965-2299(96)80026-4.
  • Lohnberg JA, Altmaier EM. A review of psychosocial factors in complex regional pain syndrome. J Clin Psychol Med Settings. 2013;20(2):247–254. doi: 10.1007/S10880-012-9322-3.
  • Edwards RR, Smith MT, Kudel I, et al. Pain-related catastrophizing as a risk factor for suicidal ideation in chronic pain. Pain. 2006;126(1-3):272–279. doi: 10.1016/J.PAIN.2006.07.004.
  • Bodde MI, Schrier E, Krans HK, et al. Resilience in patients with amputation because of complex regional pain syndrome type I. Disabil Rehabil. 2014;36(10):838–843. doi: 10.3109/09638288.2013.822023.
  • Tang NKY, Crane C. Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links. Psychol Med. 2006;36(5):575–586. doi: 10.1017/S0033291705006859.
  • Mackey S, Feinberg S. Pharmacologic therapies for complex regional pain syndrome. Curr Pain Headache Rep. 2007;11(1):38–43. doi: 10.1007/S11916-007-0020-Z.
  • Resmini G, Ratti C, Canton G, et al. Treatment of complex regional pain syndrome. Clin Cases Miner Bone Metab. 2015;12(Suppl 1):26–30. doi: 10.11138/CCMBM/2015.12.3S.026.
  • Kalita J, Vajpayee A, Misra UK. Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial. QJM. 2006;99(2):89–95. doi: 10.1093/QJMED/HCL004.
  • Atalay N, Ercidogan O, Akkaya N, et al. Prednisolone in complex regional pain syndrome. Pain Phys. 2014;2;17(2;3):179–185. doi: 10.36076/ppj.2014/17/179.
  • Bianchi C, Rossi S, Turi S, et al. Long-term functional outcome measures in corticosteroid-treted complex regional pain syndrome. Eur J Phys Rehabil Med. 2006;42(2):103–111.
  • Jamroz A, Berger M, Winston P. Prednisone for acute complex regional pain syndrome: a retrospective cohort study. Pain Res Manag. 2020;2020:8182569. doi: 10.1155/2020/8182569.
  • Gelman B, Hsu ES. Gabapentin. In: Sinatra RS, Jahr JS, J. Watkins-Pitchford M (editors). The essence of analgesia and analgesics. Cambridge: Cambridge University Press; 2022. p. 294–297. doi: 10.1017/CBO9780511841378.071.
  • van de Vusse AC, Stomp-van den Berg SGM, Kessels AHF, et al. Randomised controlled trial of gabapentin in complex regional pain syndrome type 1 [ISRCTN84121379]. BMC Neurol. 2004;4(1):13. doi: 10.1186/1471-2377-4-13.
  • Brown S, Johnston B, Amaria K, et al. A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children. Scand J Pain. 2016;13(1):156–163. doi: 10.1016/J.SJPAIN.2016.05.039.
  • Varenna M, Adami S, Sinigaglia L. Bisphosphonates in complex regional pain syndrome type I: how do they work? Clin Exp Rheumatol. 2014;32(4):451–454.
  • Chevreau M, Romand X, Gaudin P, et al. Bisphosphonates for treatment of complex regional pain syndrome type 1: a systematic literature review and meta-analysis of randomized controlled trials versus placebo. Joint Bone Spine. 2017;84(4):393–399. doi: 10.1016/J.JBSPIN.2017.03.009.
  • Varenna M, Adami S, Rossini M, et al. Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. Rheumatology. 2013;52(3):534–542. doi: 10.1093/rheumatology/kes3.12
  • Rosenbaum SB, Gupta V, Patel P, et al. Ketamine. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.
  • Connolly SB, Prager JP, Harden RN. A systematic review of ketamine for complex regional pain syndrome. Pain Med. 2015;16(5):943–969. doi: 10.1111/PME.12675.
  • Azari P, Lindsay DR, Briones D, et al. Efficacy and safety of ketamine in patients with complex regional pain syndrome. CNS Drugs. 2012;26(3):215–228. doi: 10.2165/11595200-000000000-00000.
  • Wissel J, Müller J, Dressnandt J, et al. Management of spasticity associated pain with botulinum toxin A. J Pain Symptom Manage. 2000;20(1):44–49. doi: 10.1016/S0885-3924(00)00146-9.
  • Schilder JCM, Van Dijk JG, Dressler D, et al. Responsiveness to botulinum toxin type a in muscles of complex regional pain patients with tonic dystonia. J Neural Transm. 2014;121(7):761–767. doi: 10.1007/S00702-014-1172-8/FIGURES/2.
  • Carroll I, Clark JD, Mackey S. Sympathetic block with botulinum toxin to treat complex regional pain syndrome. Ann Neurol. 2009;65(3):348–351. doi: 10.1002/ANA.21601.
  • Siongco PRL, Rosales RL, Moore AP, et al. Botulinum neurotoxin injections for muscle-based (dystonia and spasticity) and non-muscle-based (neuropathic pain) pain disorders: a meta-analytic study. J Neural Transm. 2020;127(6):935–951. doi: 10.1007/S00702-020-02163-5/TABLES/7.
  • Lee Y, Lee CJ, Choi E, et al. Lumbar sympathetic block with botulinum toxin type a and type B for the complex regional pain syndrome. Toxins. 2018;10(4):164. doi: 10.3390/TOXINS10040164.
  • Comella CL, Jankovic J, Shannon KM, et al. Comparison of botulinum toxin serotypes a and B for the treatment of cervical dystonia. Neurology. 2005;65(9):1423–1429. doi: 10.1212/01.WNL.0000183055.81056.5C.
  • Tokuno H. Efficacy of Botulinum toxin injection in reducing limb pain in patients with complex regional pain syndrome. https://clinicaltrials.gov/ct2/show/NCT03616262
  • Singh V, Cohen SP. Prolonging sympathetic blockade for complex regional pain syndrome: is botulinum toxin the answer? Anesthesiology. 2022;136(2):261–264. doi: 10.1097/ALN.0000000000004093.
  • Eisenberg E, Shtahl S, Geller R, et al. Serum and salivary oxidative analysis in complex regional pain syndrome. Pain. 2008;138(1):226–232. doi: 10.1016/J.PAIN.2008.04.019.
  • Baykal T, Seferoglu B, Karsan O, et al. Antioxidant profile in patients with complex regional pain syndrome type I. Int J Rheum Dis. 2014;17(2):156–158. doi: 10.1111/1756-185X.12140.
  • Hernigou J, Labadens A, Ghistelinck B, et al. Vitamin C prevention of complex regional pain syndrome after foot and ankle surgery: a prospective randomized study of three hundred and twenty nine patients. Int Orthop. 2021;45(9):2453–2459. doi: 10.1007/S00264-021-05159-2/TABLES/3.
  • Jacques H, Jérôme V, Antoine C, et al. Prospective randomized study of the vitamin C effect on pain and complex pain regional syndrome after total knee arthroplasty. Int Orthop. 2021;45(5):1155–1162. doi: 10.1007/S00264-020-04936-9/TABLES/4.
  • Laumonerie P, Martel M, Tibbo ME, et al. Influence of vitamin C on the incidence of CRPS-I after subacromial shoulder surgery. Eur J Orthop Surg Traumatol. 2020;30(2):221–226. doi: 10.1007/S00590-019-02542-Z/TABLES/3.
  • Aïm F, Klouche S, Frison A, et al. Efficacy of vitamin C in preventing complex regional pain syndrome after wrist fracture: a systematic review and meta-analysis. Orthop Traumatol Surg Res. 2017;103(3):465–470. doi: 10.1016/J.OTSR.2016.12.021.
  • O’Connell NE, Wand BM, Gibson W, et al. Local anaesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database Syst Rev. 2016;7(7):CD004598. doi: 10.1002/14651858.CD004598.
  • Cheng J, Salmasi V, You J, et al. Outcomes of sympathetic blocks in the management of complex regional pain syndrome: a retrospective cohort study. Anesthesiology. 2019;131(4):883–893. doi: 10.1097/ALN.0000000000002899.
  • Visnjevac O, Costandi S, Patel BA, et al. A comprehensive Outcome-Specific review of the use of spinal cord stimulation for complex regional pain syndrome. Pain Pract. 2017;17(4):533–545. doi: 10.1111/PAPR.12513.
  • Hoikkanen T, Nissen M, Ikäheimo TM, et al. Long-Term outcome of spinal cord stimulation in complex regional pain syndrome. Neurosurgery. 2021;89(4):597–609. doi: 10.1093/NEUROS/NYA.B239
  • Graham RD, Sankarasubramanian V, Lempka SF. Dorsal root ganglion stimulation for chronic pain: hypothesized mechanisms of action. J Pain. 2022;23(2):196–211. doi: 10.1016/J.JPAIN.2021.07.008.
  • Koetsier E, Franken G, Debets J, et al. Mechanism of dorsal root ganglion stimulation for pain relief in painful diabetic polyneuropathy is not dependent on GABA release in the dorsal horn of the spinal cord. CNS Neurosci Ther. 2020;26(1):136–143. doi: 10.1111/CNS.13192.
  • Deer TR, Levy RM, Kramer J, et al. Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial. Pain. 2017;158(4):669–681. doi: 10.1097/J.PAIN.0000000000000814.
  • Koopmeiners AS, Mueller S, Kramer J, et al. Effect of electrical field stimulation on dorsal root ganglion neuronal function. Neuromodulation. 2013;16(4):304–311. doi: 10.1111/NER.12028.
  • Huygen FJPM, Liem L, Nijhuis H, et al. Evaluating dorsal root ganglion stimulation in a prospective Dutch cohort. Neuromodulation. 2019;22(1):80–86. doi: 10.1111/NER.12798.
  • Krans-Schreuder HK, Bodde MI, Schrier E, et al. Amputation for long-standing, therapy-resistant type-I complex regional pain syndrome. J Bone Joint Surg Am. 2012;94(24):2263–2268. doi: 10.2106/JBJS.L.00532.
  • Honkamp N, Amendola A, Hurwitz S, et al. Retrospective review of eighteen patients who underwent transtibial amputation for intractable pain. J Bone Joint Surg Am. 2001;83(10):1479–1483. doi: 10.2106/00004623-200110000-00003.
  • Kashy BK, Abd-Elsayed AA, Farag E, et al. Amputation as an unusual treatment for Therapy-Resistant complex regional pain syndrome, type 1. Ochsner J. 2015;15(4):441–442. doi: 10.1043/TOJ-14-0074.